Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Prepaid Assets (2021 - 2025)

Historic Prepaid Assets for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $4.2 million.

  • Aligos Therapeutics' Prepaid Assets fell 1171.19% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 1171.19%. This contributed to the annual value of $5.1 million for FY2024, which is 410.55% down from last year.
  • Per Aligos Therapeutics' latest filing, its Prepaid Assets stood at $4.2 million for Q3 2025, which was down 1171.19% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, Aligos Therapeutics' Prepaid Assets registered a high of $13.5 million during Q4 2021, and its lowest value of $3.4 million during Q2 2023.
  • Moreover, its 5-year median value for Prepaid Assets was $5.3 million (2023), whereas its average is $6.2 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 7583.26% in 2022, then crashed by 5957.93% in 2023.
  • Quarter analysis of 5 years shows Aligos Therapeutics' Prepaid Assets stood at $13.5 million in 2021, then crashed by 43.79% to $7.6 million in 2022, then tumbled by 30.16% to $5.3 million in 2023, then decreased by 4.11% to $5.1 million in 2024, then decreased by 16.95% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q3 2025, $4.9 million for Q2 2025, and $5.2 million during Q1 2025.